Computational screening of FDA-approved drugs to identify potential TgDHFR, TgPRS, and TgCDPK1 proteins inhibitors against Toxoplasma gondii
Abstract Toxoplasma gondii (T. gondii) is one of the most successful parasites in the world, because about a third of the world's population is seropositive for toxoplasmosis. Treatment regimens for toxoplasmosis have remained unchanged for the past 20 years, and no new drugs have been introduced to...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Portfolio
2023-04-01
|
| Col·lecció: | Scientific Reports |
| Accés en línia: | https://doi.org/10.1038/s41598-023-32388-9 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|